86 related articles for article (PubMed ID: 8244253)
1. Monitoring of antiviral therapy with quantitative evaluation of HBeAg: a comparison with HBV DNA testing.
Perrillo R; Mimms L; Schechtman K; Robbins D; Campbell C
Hepatology; 1993 Dec; 18(6):1306-12. PubMed ID: 8244253
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of serum hepatitis B e antigen, IgM hepatitis B core antibody and HBV DNA in monitoring the response to treatment in patients with chronic hepatitis B.
Bernard F; Raymond G; Willems B; Villeneuve JP
J Viral Hepat; 1997 Jul; 4(4):265-72. PubMed ID: 9278224
[TBL] [Abstract][Full Text] [Related]
3. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
[TBL] [Abstract][Full Text] [Related]
4. Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha.
van der Eijk AA; Niesters HG; Hansen BE; Heijtink RA; Janssen HL; Schalm SW; de Man RA
J Viral Hepat; 2006 Feb; 13(2):96-103. PubMed ID: 16436127
[TBL] [Abstract][Full Text] [Related]
5. Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B.
Heijtink RA; Kruining J; Honkoop P; Kuhns MC; Hop WC; Osterhaus AD; Schalm SW
J Med Virol; 1997 Nov; 53(3):282-7. PubMed ID: 9365897
[TBL] [Abstract][Full Text] [Related]
6. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of serum IgM anti-HBc in the natural course and during interferon treatment of chronic hepatitis B virus infection.
Marinos G; Smith HM; Naoumov NV; Williams R
Hepatology; 1994 Feb; 19(2):303-11. PubMed ID: 8294088
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of hepatitis B viral DNA by solution hybridization: comparison with DNA polymerase and hepatitis B e antigen during antiviral therapy.
Kuhns MC; McNamara AL; Perrillo RP; Cabal CM; Campbel CR
J Med Virol; 1989 Apr; 27(4):274-81. PubMed ID: 2656908
[TBL] [Abstract][Full Text] [Related]
9. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
[TBL] [Abstract][Full Text] [Related]
10. [The combined treatment with prednisolone and recombinant alpha 2-interferon of patients with chronic hepatitis B: the factors influencing the immune response].
Fedorchenko SV; Vovk AD; Rybalko SL
Ter Arkh; 1994; 66(2):24-9. PubMed ID: 8160138
[TBL] [Abstract][Full Text] [Related]
11. A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women.
Sun KX; Li J; Zhu FC; Liu JX; Li RC; Zhai XJ; Li YP; Chang ZJ; Nie JJ; Zhuang H
Vaccine; 2012 Aug; 30(36):5335-40. PubMed ID: 22749833
[TBL] [Abstract][Full Text] [Related]
12. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
[TBL] [Abstract][Full Text] [Related]
13. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
Han Y; Tang Q; Zhu W; Zhang X; You L
J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
[TBL] [Abstract][Full Text] [Related]
14. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
[TBL] [Abstract][Full Text] [Related]
15. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
Lu H; Ma LX; Xu WS; Zhang HY; Yu LJ; Duan HY
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):173-5. PubMed ID: 12681068
[TBL] [Abstract][Full Text] [Related]
16. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
Hasan KN; Rumi MA; Hasanat MA; Azam MG; Ahmed S; Salam MA; Islam LN; Hassan MS
Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
[TBL] [Abstract][Full Text] [Related]
17. Quantitative detection of hepatitis B virus DNA in sera from patients with acute hepatitis B.
Tassopoulos NC; Kuhns MC; Koutelou MG; McNamara AL; Todoulos A
Dig Dis Sci; 1993 Dec; 38(12):2156-62. PubMed ID: 8261815
[TBL] [Abstract][Full Text] [Related]
18. Incidence and determinants of spontaneous seroclearance of hepatitis B e antigen and DNA in patients with chronic hepatitis B.
Yang HI; Hung HL; Lee MH; Liu J; Jen CL; Su J; Wang LY; Lu SN; You SL; Iloeje UH; Chen CJ;
Clin Gastroenterol Hepatol; 2012 May; 10(5):527-34.e1-2. PubMed ID: 22178461
[TBL] [Abstract][Full Text] [Related]
19. Prediction of response to entecavir therapy in patients with HBeAg-positive chronic hepatitis B based on on-treatment HBsAg, HBeAg and HBV DNA levels.
Shin JW; Jung SW; Park BR; Kim CJ; Eum JB; Kim BG; Jeong ID; Bang SJ; Lee SH; Kim SR; Park NH
J Viral Hepat; 2012 Oct; 19(10):724-31. PubMed ID: 22967104
[TBL] [Abstract][Full Text] [Related]
20. [Clinical usefulness of microparticle enzyme immunoassay for HBeAg and HBeAb in chronic hepatitis B patients].
Yamashita N; Deguchi M; Hosotsubo H; Asari S
Kansenshogaku Zasshi; 1995 Dec; 69(12):1323-8. PubMed ID: 8586882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
